Literature DB >> 34534157

A Retrospective Study of Hearing Loss in Patients Diagnosed with Peroxisome Biogenesis Disorders in the Zellweger Spectrum.

John Lee1, Christine Yergeau2, Kosuke Kawai1, Nancy Braverman2, Gwenaëlle S G Géléoc1.   

Abstract

OBJECTIVES: Peroxisome Biogenesis Disorders in the Zellweger Spectrum (PBD-ZSD) are autosomal recessive disorders characterized by defects in peroxisome function, biosynthesis, and/or assembly. Despite its frequent documentation, hearing loss associated with PBD-ZSD has not been extensively characterized. The purpose of this retrospective natural history study was to better characterize the hearing loss associated with PBD-ZSD and to provide additional insight into the evaluation and management of PBD-ZSD patients with hearing loss.
DESIGN: Audiological data from medical records of 42 patients with PBD-ZSD or D-bifunctional protein deficiency were collected from an ongoing longitudinal retrospective natural history study. An initial dataset of 300 audiograms and/or audiometric test results from the 42 patients were used to characterize the degree of hearing loss, type of hearing loss, relationships between air and bone conduction thresholds, age-related changes in hearing loss, and benefit with amplification.
RESULTS: The majority of PBD-ZSD patients in this study presented with moderately-severe to severe hearing loss and relatively slow rates of longitudinal changes in hearing sensitivity. Improvements in hearing thresholds were observed with use of hearing aid amplification. Though bone conduction data were limited, air-bone gaps and air conduction threshold fluctuations observed in several patients suggest there may be an increased occurrence of mixed hearing losses in PBD-ZSD populations.
CONCLUSION: The results of this retrospective study provide insight into the hearing loss associated with PBD-ZSD, but also emphasize the need for more complete assessments of hearing loss type and middle ear function in these patients. The addition of more comprehensive datasets to the ongoing natural history study will enhance our understanding of the pathophysiology underlying PBD-ZSD and guide the development of targeted evaluation and management recommendations for patients with PBD-ZSD.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 34534157      PMCID: PMC8881323          DOI: 10.1097/AUD.0000000000001126

Source DB:  PubMed          Journal:  Ear Hear        ISSN: 0196-0202            Impact factor:   3.562


  19 in total

Review 1.  Peroxisome biogenesis disorders.

Authors:  Sabine Weller; Stephen J Gould; David Valle
Journal:  Annu Rev Genomics Hum Genet       Date:  2003       Impact factor: 8.929

2.  Fatty acid abnormality in adrenoleukodystrophy.

Authors:  M Igarashi; H H Schaumburg; J Powers; Y Kishmoto; E Kolodny; K Suzuki
Journal:  J Neurochem       Date:  1976-04       Impact factor: 5.372

3.  Clinical and biochemical spectrum of D-bifunctional protein deficiency.

Authors:  Sacha Ferdinandusse; Simone Denis; Petra A W Mooyer; Conny Dekker; Marinus Duran; Roelineke J Soorani-Lunsing; Eugen Boltshauser; Alfons Macaya; Jutta Gärtner; Charles B L M Majoie; Peter G Barth; Ronald J A Wanders; Bwee Tien Poll-The
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

4.  A PEX6-defective peroxisomal biogenesis disorder with severe phenotype in an infant, versus mild phenotype resembling Usher syndrome in the affected parents.

Authors:  Annick Raas-Rothschild; Ronald J A Wanders; Petra A W Mooijer; Jeannette Gootjes; Hans R Waterham; Alisa Gutman; Yasuyuki Suzuki; Nobuyuki Shimozawa; Naomi Kondo; Gideon Eshel; Marc Espeel; Frank Roels; Stanley H Korman
Journal:  Am J Hum Genet       Date:  2002-02-28       Impact factor: 11.025

5.  Phenotype of patients with peroxisomal disorders subdivided into sixteen complementation groups.

Authors:  A B Moser; M Rasmussen; S Naidu; P A Watkins; M McGuinness; A K Hajra; G Chen; G Raymond; A Liu; D Gordon
Journal:  J Pediatr       Date:  1995-07       Impact factor: 4.406

Review 6.  Child neurology: Zellweger syndrome.

Authors:  Paul R Lee; Gerald V Raymond
Journal:  Neurology       Date:  2013-05-14       Impact factor: 9.910

7.  Peroxisome biogenesis disorders with prolonged survival: phenotypic expression in a cohort of 31 patients.

Authors:  Bwee Tien Poll-The; Jeannette Gootjes; Marinus Duran; Johannis B C De Klerk; Liesbeth J Maillette de Buy Wenniger-Prick; Ronald J C Admiraal; Hans R Waterham; Ronald J A Wanders; Peter G Barth
Journal:  Am J Med Genet A       Date:  2004-05-01       Impact factor: 2.802

Review 8.  Zellweger spectrum disorders: clinical overview and management approach.

Authors:  Femke C C Klouwer; Kevin Berendse; Sacha Ferdinandusse; Ronald J A Wanders; Marc Engelen; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2015-12-01       Impact factor: 4.123

9.  Dysmorphic Facial Features and Other Clinical Characteristics in Two Patients with PEX1 Gene Mutations.

Authors:  Mehmet Gunduz; Ozlem Unal
Journal:  Case Rep Pediatr       Date:  2016-11-02

10.  Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood.

Authors:  Kevin Berendse; Marc Engelen; Sacha Ferdinandusse; Charles B L M Majoie; Hans R Waterham; Frédéric M Vaz; Johannes H T M Koelman; Peter G Barth; Ronald J A Wanders; Bwee Tien Poll-The
Journal:  J Inherit Metab Dis       Date:  2015-08-19       Impact factor: 4.982

View more
  1 in total

Review 1.  Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review.

Authors:  Mousumi Bose; Christine Yergeau; Yasmin D'Souza; David D Cuthbertson; Melisa J Lopez; Alyssa K Smolen; Nancy E Braverman
Journal:  Cells       Date:  2022-06-10       Impact factor: 7.666

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.